Overview of Immunotherapy in Multiple Myeloma (IMAGE)
Caption
Emerging immunotherapies in multiple myeloma mainly consist of immunomodulatory imid drugs, monoclonal antibodies, immune checkpoint inhibitors, antibody–drug conjugates, chimeric antigen receptor T cells, and bispecific T cell engagers.
Credit
Yijie Wang, Yonghuan Wang, Jingyuan Ma, Huaqing Jing, Lanting Liu, Lugui Qiu, and Mu Hao | Image source: https://doi.org/10.1097/CM9.0000000000003869
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND